Dangerous liaisons: the role of "danger" signals in the immune response to gene therapy.

Recent studies in gene transfer suggest that the innate immune system plays a significant role in impeding gene therapy. In this review, we examine factors that might influence the recruitment and activation of the innate system in the context of gene therapy. We have adopted a novel model of immunology that contends that the immune system distinguishes not between self and nonself, but between what is dangerous and what is not dangerous. In taking this perspective, we provide an alternative and complementary insight into some of the failures and successes of current gene therapy protocols.

[1]  J. Ware,et al.  Deduced amino acid sequence of mouse blood-coagulation factor IX. , 1990, Gene.

[2]  T. Palmer,et al.  Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R. Naviaux,et al.  Circulating human or canine factor IX from retrovirally transduced primary myoblasts and established myoblast cell lines grafted into murine skeletal muscle , 1992, Somatic cell and molecular genetics.

[4]  R. Naviaux,et al.  Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[5]  P. Scuderi,et al.  Stimulation of IFN-gamma, TNF-alpha, and TNF-beta secretion in IL-2-activated T cells: costimulatory roles for LFA-1, LFA-2, CD44, and CD45 molecules. , 1992, Cellular immunology.

[6]  W. Anderson,et al.  Human gene therapy. , 1992, Science.

[7]  P. Scuderi,et al.  Stimulation of IFN-γ, TNF-α, and TNF-β secretion in IL-2-activated T cells: Costimulatory roles for LFA-1, LFA-2, CD44, and CD45 molecules , 1992 .

[8]  D. Lakich,et al.  Sequence of the murine factor VIII cDNA. , 1993, Genomics.

[9]  A. Stagg,et al.  Antigen-presenting cell types. , 1993, Current opinion in immunology.

[10]  A. Nienhuis,et al.  Specific prolongation of skin graft survival following retroviral transduction of bone marrow with an allogeneic major histocompatibility complex gene. , 1993, Transplantation.

[11]  W. Anderson,et al.  Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with CD34+ selected autologous peripheral blood cells transduced with a human ADA gene. Amendment to clinical research project, Project 90-C-195, January 10, 1992. , 1993, Human gene therapy.

[12]  C. Sousa,et al.  Phagocytosis of antigens by Langerhans cells in vitro , 1993, The Journal of experimental medicine.

[13]  M. Röllinghoff,et al.  Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen‐specific T cells , 1993, European journal of immunology.

[14]  W. Anderson,et al.  Treatment of Severe Combined Immunodeficiency Disease (SCID) due to Adenosine Deaminase Deficiency with CD34+ Selected Autologous Peripheral Blood Cells Transduced with a Human ADA Gene (Amendment). National Institutes of Health , 1993 .

[15]  P. Matzinger.  Tolerance, danger, and the extended family. , 1994, Annual review of immunology.

[16]  D. Kohn,et al.  Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[17]  P. Linsley,et al.  Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. , 1994, Journal of immunology.

[18]  M. Jenkins,et al.  Surface proteins involved in T cell costimulation , 1994, Journal of leukocyte biology.

[19]  F. Sallusto,et al.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.

[20]  H. Ertl,et al.  Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses , 1995, Journal of virology.

[21]  N. Sarvetnick,et al.  Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[22]  C Danieli,et al.  Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products , 1995, The Journal of experimental medicine.

[23]  C. Caskey,et al.  A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Wilson,et al.  Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. , 1996, Virology.

[25]  M. Weitzman,et al.  Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis , 1996, Journal of virology.

[26]  A. Khoruts,et al.  The anatomy of T-cell activation and tolerance. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[27]  B. Baum,et al.  Immediate inflammatory responses to adenovirus-mediated gene transfer in rat salivary glands. , 1996, Human gene therapy.

[28]  T. Reynolds,et al.  T–cell mediated rejection of gene–modified HIV–specific cytotoxic T lymphocytes in HIV–infected patients , 1996, Nature Medicine.

[29]  M. Rudnicki,et al.  A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Leiden,et al.  Immune responses to transgene–encoded proteins limit the stability of gene expression after injection of replication–defective adenovirus vectors , 1996, Nature Medicine.

[31]  F. Sallusto,et al.  Origin, maturation and antigen presenting function of dendritic cells. , 1997, Current opinion in immunology.

[32]  L. Meuse,et al.  Constitutive expression of murine CTLA4Ig from a recombinant adenovirus vector results in prolonged transgene expression , 1997, Gene Therapy.

[33]  M. Imperiale,et al.  Promoter Attenuation in Gene Therapy: Interferon-γ and Tumor Necrosis Factor-α Inhibit Transgene Expression , 1997 .

[34]  M. Imperiale,et al.  Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression. , 1997, Human gene therapy.

[35]  R. Crystal,et al.  Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. , 1997, Human gene therapy.

[36]  D. Martineau,et al.  Anti-vector immunoglobulin induced by retroviral vectors. , 1997, Human gene therapy.

[37]  J. Nalbantoglu,et al.  Combinatorial Blockade of Calcineurin and CD28 Signaling Facilitates Primary and Secondary Therapeutic Gene Transfer by Adenovirus Vectors in Dystrophic (mdx) Mouse Muscles , 1998, Journal of Virology.

[38]  R. Vabulas,et al.  Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells , 1998, European journal of immunology.

[39]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[40]  C. Janeway,et al.  Introduction: the role of innate immunity in the adaptive immune response , 1998, Seminars in immunology.

[41]  James M. Wilson,et al.  Transduction of Dendritic Cells by DNA Viral Vectors Directs the Immune Response to Transgene Products in Muscle Fibers , 1998, Journal of Virology.

[42]  M. Bukrinsky,et al.  HIV-1 Nuclear Import: Matrix Protein Is Back on Center Stage, This Time Together with Vpr , 1998, Molecular medicine.

[43]  C. Biron.  Role of early cytokines, including alpha and beta interferons (IFN-alpha/beta), in innate and adaptive immune responses to viral infections. , 1998, Seminars in immunology.

[44]  K. Pang,et al.  Type I IFNs enhance the terminal differentiation of dendritic cells. , 1998, Journal of immunology.

[45]  P. Matzinger,et al.  An innate sense of danger. , 1998, Seminars in immunology.

[46]  D. Kohn,et al.  Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[47]  C. Biron.  Role of early cytokines, including alpha and beta interferons (IFN-α\β), in innate and adaptive immune responses to viral infections☆ , 1998 .

[48]  L. Turka,et al.  Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig , 1998, Gene Therapy.

[49]  P. Stahl,et al.  The mannose receptor is a pattern recognition receptor involved in host defense. , 1998, Current opinion in immunology.

[50]  M R Jackson,et al.  Requirements for stimulating naive CD8+ T cells via signal 1 alone. , 1998, Journal of immunology.

[51]  C. Lutzko,et al.  Genetically corrected autologous stem cells engraft, but host immune responses limit their utility in canine alpha-L-iduronidase deficiency. , 1999, Blood.

[52]  D. Kohn,et al.  Improved expression in hematopoietic and lymphoid cells in mice after transplantation of bone marrow transduced with a modified retroviral vector. , 1999, Blood.

[53]  A. Beaudet,et al.  Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors. , 1999, Human gene therapy.

[54]  Varalakshmi,et al.  Regulation of Effector Cell Functions Through the Ligation of Lymphocyte Function‐Associated Antigen‐1 and Intracellular Adhesion Molecule‐1 Leads to Spontaneous Regression of a Rat Histiocytoma , 1999, Scandinavian journal of immunology.

[55]  E. Engleman,et al.  Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration. , 1999, Clinical immunology.

[56]  R. Gazzinelli,et al.  Cytokines are critical in linking the innate and adaptive immune responses to bacterial, fungal, and parasitic infection. , 1999, Advances in internal medicine.

[57]  G. Kalpana.  Retroviral Vectors for Liver-directed Gene Therapy , 1999, Seminars in liver disease.

[58]  M. Lotze,et al.  The use of dendritic cells for cancer vaccination. , 1999, Current opinion in molecular therapeutics.

[59]  Antonio Lanzavecchia,et al.  Distinct patterns and kinetics of chemokine production regulate dendritic cell function , 1999, European journal of immunology.

[60]  P. McCray,et al.  Early-onset inflammatory responses in vivo to adenoviral vectors in the presence or absence of lipopolysaccharide-induced inflammation. , 1999, American journal of respiratory cell and molecular biology.

[61]  G. Freeman,et al.  Ox40-ligand has a critical costimulatory role in dendritic cell:T cell interactions. , 1999, Immunity.

[62]  T. Mak,et al.  T-cell co-stimulation through B7RP-1 and ICOS , 1999, Nature.

[63]  Stefania Gallucci,et al.  Natural adjuvants: Endogenous activators of dendritic cells , 1999, Nature Medicine.

[64]  C. Figdor,et al.  Co‐stimulation of T cells results in distinct IL‐10 and TNF‐α cytokine profiles dependent on binding to ICAM‐1, ICAM‐2 or ICAM‐3 , 1999, European journal of immunology.

[65]  T. Libermann,et al.  Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. , 1999, Human gene therapy.

[66]  A. Beaudet,et al.  Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[67]  T. VandenDriessche,et al.  Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[68]  D. Golenbock,et al.  Toll-like Receptor 2 Functions as a Pattern Recognition Receptor for Diverse Bacterial Products* , 1999, The Journal of Biological Chemistry.

[69]  H. Ertl,et al.  Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[70]  R. Samulski,et al.  Adeno-associated virus vectors for gene therapy: more pros than cons? , 2000, Molecular medicine today.

[71]  A. Bruce,et al.  Sustained expression of human factor VIII in mice using a parvovirus-based vector. , 2000, Blood.

[72]  J. Feldon,et al.  Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain , 2000, Gene Therapy.

[73]  Douglas T. Golenbock,et al.  Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus , 2000, Nature Immunology.

[74]  C. Janeway,et al.  How does the immune system distinguish self from nonself? , 2000, Seminars in immunology.

[75]  J. Tisdale,et al.  Introduction of a xenogeneic gene via hematopoietic stem cells leads to specific tolerance in a rhesus monkey model. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[76]  R M Zinkernagel,et al.  Localization dose and time of antigens determine immune reactivity. , 2000, Seminars in immunology.

[77]  G. Ciancio,et al.  Current treatment practice in immunosuppression , 2000, Expert opinion on pharmacotherapy.

[78]  A. Krieg,et al.  The role of CpG motifs in innate immunity. , 2000, Current opinion in immunology.

[79]  G. Weiner.  The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides , 2000, Journal of leukocyte biology.

[80]  P. Opolon,et al.  The role of IL‐6 in the inflammatory and humoral response to adenoviral vectors , 2000, The journal of gene medicine.

[81]  S. Akira,et al.  Toll-like receptors: lessons from knockout mice. , 2000, Biochemical Society transactions.

[82]  C. Balagué,et al.  Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector. , 2000, Blood.

[83]  J. Escobedo,et al.  Dose response to a single intramuscular injection of recombinant adeno-associated virus-erythropoietin in monkeys. , 2000, The Journal of surgical research.

[84]  Theresa A. Storm,et al.  Nonrandom Transduction of Recombinant Adeno-Associated Virus Vectors in Mouse Hepatocytes In Vivo: Cell Cycling Does Not Influence Hepatocyte Transduction , 2000, Journal of Virology.

[85]  A. Coutinho.  Germ-line selection ensures embryonic autoreactivity and a positive discrimination of self mediated by supraclonal mechanisms. , 2000, Seminars in immunology.

[86]  A. Ramsay,et al.  Cytokines in innate and adaptive immunity. , 2000, Reviews in immunogenetics.

[87]  M. Kay,et al.  Therapeutic levels of human factor VIII and IX using HIV-1-based lentiviral vectors in mouse liver. , 2000, Blood.

[88]  B. Lemaître,et al.  Gram-negative Bacteria-binding Protein, a Pattern Recognition Receptor for Lipopolysaccharide and β-1,3-Glucan That Mediates the Signaling for the Induction of Innate Immune Genes in Drosophila melanogaster Cells* , 2000, The Journal of Biological Chemistry.

[89]  David A. Williams,et al.  Gene Therapy 2000. , 2000, Hematology. American Society of Hematology. Education Program.

[90]  F. Cosset,et al.  T Cell‐specific expression from Mo‐MLV retroviral vectors containing a CD4 mini‐promoter/enhancer , 2000, The journal of gene medicine.

[91]  S. Dzik,et al.  The immunological synapse: A molecular machine controlling T cell activation , 2000 .

[92]  B. Kwon,et al.  Co‐stimulation of antigen‐specific CD4 T cells by 4‐1BB ligand , 2000, European journal of immunology.

[93]  A. Aderem,et al.  Toll-like receptors in the induction of the innate immune response , 2000, Nature.

[94]  A. Tauber,et al.  Moving beyond the immune self? , 2000, Seminars in immunology.

[95]  Seng H. Cheng,et al.  Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[96]  R. Crystal,et al.  Antivector and antitransgene host responses in gene therapy. , 2000, Current opinion in molecular therapeutics.

[97]  M Cohn,et al.  A minimal model for the self-nonself discrimination: a return to the basics. , 2000, Seminars in immunology.

[98]  S. Fawell,et al.  Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[99]  C. Broeckhoven,et al.  Gene-based cancer vaccines: an ex vivo approach , 2001, Leukemia.

[100]  J. Bromberg,et al.  TNFα and IFNγ Induced by Innate Anti-adenoviral Immune Responses Inhibit Adenovirus-Mediated Transgene Expression , 2001 .

[101]  F. Moreau-Gaudry,et al.  High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors. , 2001, Blood.

[102]  J. Wilson,et al.  Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[103]  P. Matzinger,et al.  Danger signals: SOS to the immune system. , 2001, Current opinion in immunology.

[104]  D. Scandella,et al.  interaction in a mouse model of hemophilia A Long-term induction of immune tolerance after blockade of CD 40-CD 40 L , 2001 .

[105]  J. Mizgerd,et al.  Early Response Cytokines and Innate Immunity: Essential Roles for TNF Receptor 1 and Type I IL-1 Receptor During Escherichia coli Pneumonia in Mice1 , 2001, The Journal of Immunology.

[106]  J. Wilson,et al.  Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[107]  R. Nagel,et al.  Correction of Sickle Cell Disease in Transgenic Mouse Models by Gene Therapy , 2001, Science.

[108]  M. Rämet,et al.  Toll-like Receptors as Sensors of Pathogens , 2001, Pediatric Research.

[109]  P. Matzinger,et al.  Liver transplants induce deletion of liver-specific T cells. , 2001, Transplantation proceedings.

[110]  K. Elkon,et al.  Variation in Adenovirus Transgene Expression between BALB/c and C57BL/6 Mice Is Associated with Differences in Interleukin-12 and Gamma Interferon Production and NK Cell Activation , 2001, Journal of Virology.

[111]  C. Walsh,et al.  Induction of tolerance to human factor VIII in mice. , 2001, Blood.

[112]  R. Johnson,et al.  Induction of cytotoxic T lymphocyte and antibody responses to enhanced green fluorescent protein following transplantation of transduced CD34(+) hematopoietic cells. , 2001, Blood.

[113]  G. Ciliberto,et al.  An improved helper-dependent adenoviral vector allows persistent gene expression after intramuscular delivery and overcomes preexisting immunity to adenovirus , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[114]  R. Herzog,et al.  Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutation. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[115]  S. Kochanek,et al.  Local high-capacity adenovirus-mediated mCTLA4Ig and mCD40Ig expression prolongs recombinant gene expression in skeletal muscle. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[116]  J. Bromberg,et al.  TNFalpha and IFNgamma induced by innate anti-adenoviral immune responses inhibit adenovirus-mediated transgene expression. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[117]  内田 哲也.  Co-administration of adenovirus vector expressing CTLA4-Ig prolongs transgene expression in the brain of mice sensitized with adenovirus , 2001 .

[118]  C. Dunbar.  Lentiviruses get specific , 2002 .

[119]  D. Pardoll,et al.  Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells. , 2002, Blood.